Oxytocin–ergometrine co‐administration does not reduce blood loss at caesarean delivery for labour arrest *
暂无分享,去创建一个
J. Kingdom | R. Windrim | M. Balki | S. Kasodekar | S. Dhumne | J. Carvalho
[1] J. Kingdom,et al. Complications of Exteriorized Compared With In Situ Uterine Repair at Cesarean Delivery Under Spinal Anesthesia: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.
[2] T. Liabsuetrakul,et al. Prophylactic use of ergot alkaloids in the third stage of labour. , 2007, The Cochrane database of systematic reviews.
[3] Steven W. Heim,et al. Preventing postpartum hemorrhage: managing the third stage of labor. , 2006, American family physician.
[4] J. Kingdom,et al. Minimum Oxytocin Dose Requirement After Cesarean Delivery for Labor Arrest , 2006, Obstetrics and gynecology.
[5] Arzu Ozkan,et al. The effect of placental removal method and site of uterine repair on postcesarean endometritis and operative blood loss , 2005, Acta obstetricia et gynecologica Scandinavica.
[6] F. Njokanma,et al. Uterine incision closure at caesarean section: a randomised comparative study of intraperitoneal closure and closure after temporary exteriorisation. , 2005, West African journal of medicine.
[7] J. Kingdom,et al. Oxytocin Requirements at Elective Cesarean Delivery: A Dose-Finding Study , 2004, Obstetrics and gynecology.
[8] N. Hameed,et al. Maternal blood loss by expansion of uterine incision at caesarean section--a comparison between sharp and blunt techniques. , 2004, Journal of Ayub Medical College, Abbottabad : JAMC.
[9] G. Penney,et al. Quantifying severe maternal morbidity: a Scottish population study , 2004, BJOG : an international journal of obstetrics and gynaecology.
[10] S. Higgins,et al. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. , 2004, The Cochrane database of systematic reviews.
[11] Peisheng Zhang,et al. Oxytocin-induced desensitization of the oxytocin receptor. , 2003, American journal of obstetrics and gynecology.
[12] G. Cooper,et al. Maternal deaths from anaesthesia. An extract from Why mothers die 1997-1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom. , 2002, British journal of anaesthesia.
[13] G. Shorten,et al. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. , 2002, International journal of obstetric anesthesia.
[14] Disciplinary Committee,et al. Royal Pharmaceutical Society of Great Britain , 2002 .
[15] D. Elbourne,et al. Prophylactic use of oxytocin in the third stage of labour. , 2001, The Cochrane database of systematic reviews.
[16] D. Chestnut,et al. Comparison of Two Oxytocin Regimens to Prevent Uterine Atony at Cesarean Delivery: A Randomized Controlled Trial , 2001, Obstetrics and gynecology.
[17] D. Timmerman,et al. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double–blind randomised trial , 1999, British journal of obstetrics and gynaecology.
[18] T. Vree,et al. Current Status and Review of Clinical Pharmacology and Therapeutic Use Compared with Other Oxytocics in Obstetrics and Gynaecology , 1998 .
[19] T. Vree,et al. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. , 1998, Drugs.
[20] Mitchell Gg,et al. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. , 1993 .
[21] D. Elbourne,et al. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. , 1993, The Online journal of current clinical trials.
[22] R. Markello,et al. Cardiovascular Effects of Oxytocin , 1975, Obstetrics and gynecology.